Metraipolis › archive › dc_ae76be336732
CYP2C19 genotype-guided escalation to ticagrelor vs. clopidogrel in secondary stroke prevention: a retrospective cohort study — Europe PMC PMID:41727544
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41727544
- DOI
- 10.3389/fphar.2026.1747121
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T01:26:30.178Z
- SHA-256 of the archived text
e1b2082339f24d549c6ad16109f1594b0bc8b4d81c89d8acbb2eb47820be84e3- Stable URL of this page
https://metraipolis.com/documento/dc_ae76be336732
How to cite
CYP2C19 genotype-guided escalation to ticagrelor vs. clopidogrel in secondary stroke prevention: a retrospective cohort study — Europe PMC PMID:41727544 — Europe PMC (en), https://europepmc.org/article/MED/41727544 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ae76be336732 (Metraipolis archive dc_ae76be336732, sha256 e1b2082339f24d549c6ad16109f1594b0bc8b4d81c89d8acbb2eb47820be84e3)
BibTeX
@misc{dcae76be336732,
title = {CYP2C19 genotype-guided escalation to ticagrelor vs. clopidogrel in secondary stroke prevention: a retrospective cohort study — Europe PMC PMID:41727544},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41727544},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ae76be336732; sha256 e1b2082339f24d549c6ad16109f1594b0bc8b4d81c89d8acbb2eb47820be84e3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41727544. Agents can read the archived copy with the MCP tool read_document.